Key result
EASIX strongly predicts cardiorenal syndrome in CKD patients with an AUC of ~0.82.
Why the study?
To investigate the predictive value of endothelial activation and the endothelial activation and stress index (EASIX) for chronic kidney disease (CKD) patients with cardiorenal syndrome (CRS).
Does the endothelial activation and stress index (EASIX) predict the presence of cardiorenal syndrome in patients with chronic kidney disease?
Observational (n=253)
No
Does the endothelial activation and stress index (EASIX) predict the presence of cardiorenal syndrome in patients with chronic kidney disease?
EASIX demonstrates high predictive value for identifying cardiorenal syndrome in patients with chronic kidney disease.
Answers are grounded in this paper and cite their sources.
EASIX may support risk stratification in CKD with CRS; leaves open whether prospective validation alters management.
This study aimed to investigate predictive value of endothelial activation and the endothelial activation and stress index (EASIX) for chronic kidney disease (CKD) patients with cardiorenal syndrome (CRS). A retrospective study was conducted on 253 CKD patients admitted to our hospital from January 2021 to June 2024. Patients were divided into CRS group (n = 77) and non-CRS group (n = 176). Univariate and binary Logistics regression analyses were performed to identify influencing factors. The receiver operating characteristic (ROC) curve was used to evaluate the predictive value of EASIX for CKD patients with CRS. There were significant differences in terms of hypertension, red blood cell count, red cell distribution width (RDW), blood urea nitrogen, albumin, interleukin-6, C-reactive protein, EASIX, and CKD stage between the 2 groups ( P < .05). Binary Logistics regression analysis indicated that RDW, EASIX, and CKD stagings were independent influencing factors for CKD patients with CRS ( P < .05). The predictive area under the curve (AUC) for EASIX was 0.821 with a standard error of 0.028 (95% confidence interval [CI]: 0.767–0.876), with a Youden index of 0.62, sensitivity of 85.71%, and specificity of 76.14%. The AUC for RDW was 0.742, with a standard error of 0.035 (95% CI: 0.674–0.811), Youden index of 0.48, sensitivity of 77.92%, and specificity of 69.32%. The AUC for CKD stage was 0.737, with a standard error of 0.032 (95% CI: 0.675–0.799), Youden index of 0.47, sensitivity of 92.21%, and specificity of 55.11%. Post-treatment patients with EASIX ≤ 3.18 had higher blood calcium levels and lower blood phosphorus levels compared to those with EASIX > 3.18, with significant differences ( P < .05). EASIX demonstrates high predictive value in predicting CKD patients with CRS, suggesting its inclusion as an evaluation index.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) conducted an observational in Chronic kidney disease (CKD) with cardiorenal syndrome (CRS) (n=253). Endothelial activation and stress index (EASIX) was evaluated on Predictive value of EASIX for CRS in CKD patients (AUC 0.821, 95% CI 0.767-0.876, p=<.05). The endothelial activation and stress index (EASIX) demonstrated high predictive value for identifying cardiorenal syndrome in patients with chronic kidney disease (AUC 0.821; 95% CI 0.767-0.876).
Synapse has enriched 10 related papers. Consider them for comparative context: